[{"id":"869d4b1c-639c-41c3-8658-c66b539f27d4","acronym":"","url":"https://clinicaltrials.gov/study/NCT01635296","created_at":"2021-01-18T07:01:44.816Z","updated_at":"2024-07-02T16:37:27.996Z","phase":"Phase 1b","brief_title":"A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia","source_id_and_acronym":"NCT01635296","lead_sponsor":"Hoffmann-La Roche","biomarkers":" GDF15","pipe":"","alterations":" ","tags":["GDF15"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • RG7112"],"overall_status":"Completed","enrollment":" Enrollment 43","initiation":"Initiation: 07/01/2012","start_date":" 07/01/2012","primary_txt":" Primary completion: 10/01/2013","primary_completion_date":" 10/01/2013","study_txt":" Completion: 10/01/2013","study_completion_date":" 10/01/2013","last_update_posted":"2016-11-02"},{"id":"9d592f29-668a-459f-bc26-c2d88cb5b5e3","acronym":"","url":"https://clinicaltrials.gov/study/NCT01605526","created_at":"2021-01-18T06:52:01.859Z","updated_at":"2024-07-02T16:37:27.911Z","phase":"Phase 1","brief_title":"A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma","source_id_and_acronym":"NCT01605526","lead_sponsor":"Hoffmann-La Roche","biomarkers":" GDF15","pipe":"","alterations":" ","tags":["GDF15"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e doxorubicin hydrochloride • RG7112"],"overall_status":"Completed","enrollment":" Enrollment 23","initiation":"Initiation: 05/01/2012","start_date":" 05/01/2012","primary_txt":" Primary completion: 06/01/2013","primary_completion_date":" 06/01/2013","study_txt":" Completion: 06/01/2013","study_completion_date":" 06/01/2013","last_update_posted":"2016-11-02"},{"id":"fd563325-9df9-485a-b6ff-838f9e7157b4","acronym":"","url":"https://clinicaltrials.gov/study/NCT00623870","created_at":"2021-01-18T02:19:08.304Z","updated_at":"2024-07-02T16:37:28.003Z","phase":"Phase 1","brief_title":"A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.","source_id_and_acronym":"NCT00623870","lead_sponsor":"Hoffmann-La Roche","biomarkers":" CD33 • CD34 • GDF15","pipe":"","alterations":" ","tags":["CD33 • CD34 • GDF15"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RG7112"],"overall_status":"Completed","enrollment":" Enrollment 116","initiation":"Initiation: 05/01/2008","start_date":" 05/01/2008","primary_txt":" Primary completion: 11/01/2012","primary_completion_date":" 11/01/2012","study_txt":" Completion: 11/01/2012","study_completion_date":" 11/01/2012","last_update_posted":"2016-11-02"}]